These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14455716)

  • 1. [Comparative evaluation of therapeutic methods in cancer of the urinary bladder].
    KHRUSHCHEV VI
    Urol Mosc; 1961; 26():46-52. PubMed ID: 14455716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of mono- and biactive electrocoagulation of tumors of the urinary bladder].
    TAUKENOV MT
    Zdravookhranenie Kazakhstana; 1961; 21(10)():16-20. PubMed ID: 13919854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Retroperitoneoscopy in diagnosis of lymphogenic metastases of bladder cancer].
    Matveev BP; Shipilov VI; Ali-Zade AM
    Vopr Onkol; 1984; 30(8):87-90. PubMed ID: 6237498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Further results of comparative therapeutic experiments with mustard gas in inoperable cancer of the bladder of different cell types].
    WOLTERHOFF H
    Z Urol; 1953; 46(9):606-23. PubMed ID: 13170474
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE ROLE OF URINARY STASIS IN THE PATHOGENESIS OF CANCER OF THE URINARY BLADDER].
    PERELMAN VM; SHABAD AL
    Vopr Onkol; 1963; 9():82-7. PubMed ID: 14139242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer].
    Hayashi Y; Tawada T; Ando Y
    Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
    Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA
    J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].
    Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
    Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problem of urinary bladder cancer--an attempt at a therapeutic standard].
    Langkopf B; Hofmann W
    Z Urol Nephrol; 1987 Nov; 80(11):647-51. PubMed ID: 2449781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer].
    Kurokawa S; Morita T; Muraishi O; Tokue A
    Hinyokika Kiyo; 2001 Apr; 47(4):247-50. PubMed ID: 11411098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An evaluation of damage caused by radiation and chemical drugs to urinary bladder mucosa in stage T1-T2N0V0 cancer].
    Kaprin AD; Pan'shin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2007; 53(4):473-6. PubMed ID: 17969414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plastic repair of the urinary bladder].
    Bondar' GV; Bulava VV; Panova LA
    Vopr Onkol; 1976; 22(7):98-102. PubMed ID: 997414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer of the bladder and urinary tract.
    TURLEY HK
    Memphis Med J; 1946 Sep; 21():138. PubMed ID: 20999740
    [No Abstract]   [Full Text] [Related]  

  • 15. [CANCER OF THE URINARY BLADDER DIVERTICULUM].
    MISHEV P
    Khirurgiia (Sofiia); 1965; 18():123-4. PubMed ID: 14317672
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal models of urinary bladder cancer and their application to novel drug discovery.
    Oliveira PA; Arantes-Rodrigues R; Vasconcelos-Nóbrega C
    Expert Opin Drug Discov; 2014 May; 9(5):485-503. PubMed ID: 24670247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study on the etiology of urinary bladder cancer in Istanbul, Turkey.
    Yaris F; Dikici MF; Sabuncu HH; Yaris E
    Asian Pac J Cancer Prev; 2006; 7(4):591-4. PubMed ID: 17250433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiomyoma of the urinary bladder presenting as urinary retention in the female.
    Saunders SE; Conjeski JM; Zaslau S; Williams J; Kandzari SJ
    Can J Urol; 2009 Aug; 16(4):4762-4. PubMed ID: 19671234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer.
    Mutlu N; Turkeri L; Emerk K
    Clin Chem Lab Med; 2003 Aug; 41(8):1069-74. PubMed ID: 12964816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.